Is Neoadjuvant Chemotherapy in Malignant Pleural Mesothelioma Beneficial?
Neoadjuvant chemotherapy was found to negatively impact survival in resectable malignant pleural mesothelioma.
Latest Features
LATEST ARTICLES
Chronic Lymphocytic Leukemia Treatment Decision Making With Venetoclax-Based Therapy
A review of case studies that outline treatment decisions based on patient and disease characteristics.
CAR-NK Cells Make Their Debut in Hematologic Cancers
The new type of adoptive cell therapy showed a response in 8 of 11 patients with hematologic malignancies in a clinical study.
Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation
The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing.
Prostate MRI Improves Confirmatory Biopsy Sensitivity
MRI-guided confirmatory prostate biopsies more accurately detects grade progression among men on active surveillance for prostate cancer compared with TRUS-guided systematic biopsies alone.
Salvage Radiotherapy Called a Viable Option for Recurrent Prostate Cancer
The authors of new review say the results of the JCOG0401 trial suggest that standard hormonal therapy alone vs salvage radiotherapy is not an appropriate management strategy for recurrence after radical prostatectomy.
Large Consortium Study Reveals More Details on the Link Between Viruses and Cancer
Researchers use whole-genome and whole-transcriptome sequencing data to reveal viral sequences in cancer tissue.
Breast Cancer in Women vs Men: Prolonged Survival in Women May Be Influenced by Lead-Time Bias
Recent studies suggest that some misunderstanding around lead-time bias continues to persist in the literature.
Combating COVID-19: Best Practices That Clinicians Need to Know
How should clinicians combat coronavirus disease (COVID-19) in their practice settings?
Navigating the Homeless Patient Through Cancer Care
Homelessness is a significant barrier to cancer care. An oncology social worker gives pointers on addressing barriers and obtaining pertinent information.
“Medical Distancing” May Help Protect Cancer Patients From Exposure to COVID-19
Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection.
Do Patients With Cancer Need Disease-Specific Precautions to Prevent COVID-19 Infection?
Although some patients with cancer are at higher risk of developing severe disease should they become infected, these experts suggest the precautions being given to the general population are sufficient — at least for now.
Federal Ruling Puts Pressure on Clinical Trial Sponsors to Post Data
A federal ruling will force trial sponsors to post basic results on ClinicalTrials.gov, but it is unclear whether this is a feasible mandate.
Treatment Options for Pancreatic Neuroendocrine Tumors
In the management of PNETs it is important to differentiate between functional and nonfunctional PNETs in order to determine the course of treatment.
An Early Look at When CAR-T Therapy Fails Patients With CLL
A study showed how long patients with CLL may live after CAR-T therapy failure, providing a benchmark for trials evaluating therapies in the post–CAR-T setting.
Want to read more?
Please login or register first to view this content.
